This is out Library. Please click on the article title to view the details.
submitted by: admin on 06/28/2015
This PowerPoint presentation on Beyond Mammography reviews the challenges we're facing with mammography as a screening test and the need for bringing breast thermography forward to improve both the sensitivitly of finding breast cancers as well as the specificity that reflects its accuracy.
submitted by: admin on 09/19/2013
The FDA published information in Journal Watch in June of 2011 that is packed with presumptive and incorrect information about breast thermography and they have to know it! Breast thermography was approved in 1982 as an adjunct to mammography to evaluate for breast cancer. In 2004 the FDA rejected breast thermography as a stand alone test for breast...
submitted by: admin on 09/19/2013
Do digital mammograms add much over conventional mammograms, especially for premenopausal women? How much radiation is saved? Are they safe in genetic forms of cancer? Are we finding too many cancers?
submitted by: admin on 11/02/2024
Between 30 and 50% of new breast cancer diagnoses are found on mammography screenings and are classified as ductal carcinoma in situ, or DCIS. Most of these "cancers" are not cancer at all. In fact about 97% are benign lesions that can be followed over time quite safely. Most cases of DCIS would be better off under-diagnosed and under-treated.
Unfortunately,...
submitted by: admin on 09/03/2014
This is a PowerPoint presentation on why doctors should expand the boundaries of breast cancer screening by including breast thermography. The FDA approved this test in 1982 as an adjunct to mammography. Because it adds important information about the physiology of how breast cancers behave rather than just their anatomy, so it adds an additional valuable way...
submitted by: admin on 02/17/2015
There is considerable confusion about the role of mammograms in breast cancer detection in premenopausal women. The US is the only country in the world making the recommendation that they be done on women under the age of 50. The people standing to profit from doing mammograms in this age group are the mammogram industry, Big Pharma in the sale of chemotherapy,...
submitted by: admin on 11/02/2024
Mammograms are a poor screening test for premenopausal women. There are too many false positive and negative findings. Breast thermography is the answer. They have not been widely accepted.
submitted by: admin on 06/18/2016
Screening mammograms could be doing more harm than good according to an article published in the British Medical Journal in December of 2011. The benefits of mammograms were not so apparent because of the risk for overtreatment. Data showed that for every 2000 women taking a mammogram throughout 10 years, one will have her life prolonged, and 10 healthy...